The identification of an ultra-high risk (UHR) profile for psychosis and a greater understanding of its prodrome have led to increasing interest in early intervention to delay or prevent the onset of psychotic illness. In a randomized placebo-controlled trial, we have identified long-chain ω-3 (ω-3) polyunsaturated fatty acid (PUFA) supplementation as potentially useful, as it reduced the rate of transition to psychosis by 22.6% 1 year after baseline in a cohort of 81 young people at UHR of transition to psychosis. However, the mechanisms whereby the ω-3 PUFAs might be neuroprotective are incompletely understood. Here, we report on the effects of ω-3 PUFA supplementation on intracellular phospholipase A2 (inPLA(2)) activity, the main enzyme...
While the role of omega-3 polyunsaturated fatty acids (PUFAs) in physical health is well established...
Previous efforts in the prospective evaluation of individuals who experience attenuated psychotic sy...
BACKGROUND NEURAPRO was a multicenter, placebo-controlled trial of long-chain omega-3 polyunsatur...
Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) are necessary for optimum mental health,...
Aim: A promising approach of indicated prevention in individuals at increased risk of psychosis was ...
Long-chain omega-3 polyunsaturated fatty acids (PUFAs) are essential for neural development and func...
AIM: A promising approach of indicated prevention in individuals at increased risk of psychosis was ...
Background: Deficiencies in membrane polyunsaturated fatty acids (PUFA) such as omega-3 (n-3) fatty ...
People classified as ultra-high risk (UHR) of developing psychosis have reduced cellular membrane om...
Background: Deficiencies in membrane polyunsaturated fatty acids (PUFA) such as omega-3 (n-3) fatty ...
A promising treatment to prevent onset and improve outcomes in patients at ultrahigh risk for psycho...
OBJECTIVE: To investigate whether long-chain omega-3 (n-3) polyunsaturated fatty acids (PUFAs) impro...
Omega-3 long-chain polyunsaturated fatty acids (ω-3 LC-PUFAs) are thought to be important for normal...
Growing evidence suggests the clinical usefulness of omega (ω)-3 polyunsaturated fatty acids (PUFA) ...
Aim: Among different types of poly unsaturated fatty acids, omega-3 fatty acids (FA) play a substant...
While the role of omega-3 polyunsaturated fatty acids (PUFAs) in physical health is well established...
Previous efforts in the prospective evaluation of individuals who experience attenuated psychotic sy...
BACKGROUND NEURAPRO was a multicenter, placebo-controlled trial of long-chain omega-3 polyunsatur...
Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) are necessary for optimum mental health,...
Aim: A promising approach of indicated prevention in individuals at increased risk of psychosis was ...
Long-chain omega-3 polyunsaturated fatty acids (PUFAs) are essential for neural development and func...
AIM: A promising approach of indicated prevention in individuals at increased risk of psychosis was ...
Background: Deficiencies in membrane polyunsaturated fatty acids (PUFA) such as omega-3 (n-3) fatty ...
People classified as ultra-high risk (UHR) of developing psychosis have reduced cellular membrane om...
Background: Deficiencies in membrane polyunsaturated fatty acids (PUFA) such as omega-3 (n-3) fatty ...
A promising treatment to prevent onset and improve outcomes in patients at ultrahigh risk for psycho...
OBJECTIVE: To investigate whether long-chain omega-3 (n-3) polyunsaturated fatty acids (PUFAs) impro...
Omega-3 long-chain polyunsaturated fatty acids (ω-3 LC-PUFAs) are thought to be important for normal...
Growing evidence suggests the clinical usefulness of omega (ω)-3 polyunsaturated fatty acids (PUFA) ...
Aim: Among different types of poly unsaturated fatty acids, omega-3 fatty acids (FA) play a substant...
While the role of omega-3 polyunsaturated fatty acids (PUFAs) in physical health is well established...
Previous efforts in the prospective evaluation of individuals who experience attenuated psychotic sy...
BACKGROUND NEURAPRO was a multicenter, placebo-controlled trial of long-chain omega-3 polyunsatur...